Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
F 5.08 -8.14% -0.45
ASMB closed down 8.14 percent on Friday, February 26, 2021, on 1.97 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ASMB trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion -8.14%
Oversold Stochastic Weakness -8.14%
Stochastic Buy Signal Bullish -9.93%
Oversold Stochastic Weakness -9.93%
Gapped Down Weakness -6.96%
Lower Bollinger Band Touch Weakness -6.96%
Older End-of-Day Signals for ASMB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Assembly Biosciences, Inc. Description

Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Gastroenterology Digestive System Digestive System Surgery Fecal Incontinence Gastrointestinal Products Large Intestine Phenylephrine

Is ASMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.84
52 Week Low 4.78
Average Volume 1,214,684
200-Day Moving Average 14.59
50-Day Moving Average 6.01
20-Day Moving Average 5.96
10-Day Moving Average 5.76
Average True Range 0.32
ADX 19.01
+DI 17.65
-DI 32.80
Chandelier Exit (Long, 3 ATRs ) 6.05
Chandelier Exit (Short, 3 ATRs ) 6.04
Upper Bollinger Band 6.74
Lower Bollinger Band 5.17
Percent B (%b) -0.06
BandWidth 26.33
MACD Line -0.19
MACD Signal Line -0.09
MACD Histogram -0.094
Fundamentals Value
Market Cap 167.75 Million
Num Shares 33 Million
EPS -3.66
Price-to-Earnings (P/E) Ratio -1.39
Price-to-Sales 2.42
Price-to-Book 0.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.79
Resistance 3 (R3) 5.86 5.70 5.67
Resistance 2 (R2) 5.70 5.52 5.66 5.63
Resistance 1 (R1) 5.39 5.41 5.31 5.32 5.59
Pivot Point 5.23 5.23 5.19 5.19 5.23
Support 1 (S1) 4.92 5.05 4.84 4.85 4.57
Support 2 (S2) 4.76 4.94 4.72 4.53
Support 3 (S3) 4.45 4.76 4.49
Support 4 (S4) 4.38